How To Download Mp4 From Youtube To Usb __FULL__
Dimple Demay
To convert an ordinary object that's not iterable or array-like to an array (by enumerating its property keys, values, or both), use Object.keys(), Object.values(), or Object.entries(). To convert an async iterable to an array, use Array.fromAsync().
Array.from() has an optional parameter mapFn, which allows you to execute a function on each element of the array being created, similar to map(). More clearly, Array.from(obj, mapFn, thisArg) has the same result as Array.from(obj).map(mapFn, thisArg), except that it does not create an intermediate array, and mapFn only receives two arguments (element, index) without the whole array, because the array is still under construction.
Note: This behavior is more important for typed arrays, since the intermediate array would necessarily have values truncated to fit into the appropriate type. Array.from() is implemented to have the same signature as TypedArray.from().
The Array.from() method is a generic factory method. For example, if a subclass of Array inherits the from() method, the inherited from() method will return new instances of the subclass instead of Array instances. In fact, the this value can be any constructor function that accepts a single argument representing the length of the new array. When an iterable is passed as arrayLike, the constructor is called with no arguments; when an array-like object is passed, the constructor is called with the normalized length of the array-like object. The final length will be set again when iteration finishes. If the this value is not a constructor function, the plain Array constructor is used instead.
It turns out it comes from an April 2009 Everyday Food magazine, a shuttered Martha Stewart publication that was wonderful in every way. The focus was on weekday cooking for regular people with busy lives but the food was special. It was eventually folded into Living magazine and (I think) has dissipated* from there. This omelet perfectly exemplifies what everyday but special can look like because the ingredients are simple (frozen spinach, cheddar, eggs, milk), the process is quick (hand-whisked, bakes in under 15 minutes), but the presentation is gorgeous enough for the fanciest holiday brunch spread.
The assessment examines the magnitude and severity of marine litter and plastic pollution and reviews existing solutions and actions. The assessment demonstrates that there is a growing threat from marine litter and plastic pollution in all ecosystems from source to sea. It provides a comprehensive update on current research (and knowledge gaps) with respect to direct impacts on marine life, risks posed to ecosystems and human health, and social and economic costs.
Pressures on water resources are increasing unsustainably. Integrated Water Resources Management (IWRM) brings people from all sectors together to ensure that water resources are managed sustainably, fairly and efficiently. If we are to have any chance of achieving a world in balance by 2030, we need to double the rate at which we are putting IWRM into practice.
Alert: USPS.com is undergoing routine maintenance from 10 PM ET, Saturday, July 15 through 4 AM ET, Sunday July 16, 2023. During this time, you may not be able to sign into your account and payment transactions on some applications will be temporarily unavailable. We apologize for any inconvenience.
Informed Delivery is a free service from USPS that shows you preview images of incoming mail, as well as status updates about your incoming and outbound packages. You can see those notifications in a morning Daily Digest email, or at any time via the dashboard from your phone, computer, or the USPS Mobile app. Informed Delivery also has other features that make tracking and receiving your packages easier and more convenient.
The results of tests performed by clinical laboratories nationwide are summarized below. Data from clinical laboratories (the percentage of specimens tested that are positive for influenza virus) are used to monitor whether influenza activity is increasing or decreasing.
The results of tests performed by public health laboratories nationwide are summarized below. Data from public health laboratories are used to monitor the proportion of circulating influenza viruses that belong to each influenza subtype/lineage.
CDC performs genetic and antigenic characterization of U.S. viruses submitted from state and local public health laboratories according to the Right Size Roadmap submission guidance. These data are used to compare how similar the currently circulating influenza viruses are to the reference viruses representing viruses contained in the current influenza vaccines. The data are also used to monitor evolutionary changes that continually occur in influenza viruses circulating in humans. CDC also tests susceptibility of circulating influenza viruses to antiviral medications including the neuraminidase inhibitors (oseltamivir, zanamivir, and peramivir) and the PA endonuclease inhibitor baloxavir.
High levels of resistance to the adamantanes (amantadine and rimantadine) persist among influenza A(H1N1)pdm09 and influenza A(H3N2) viruses (the adamantanes are not effective against influenza B viruses). Therefore, use of these antivirals for treatment and prevention of influenza A virus infection is not recommended and data from adamantane resistance testing are not presented.
About 70% of ILINet participants provide both the number of patient visits for respiratory illness and the total number of patient visits for the week broken out by age group. Data from this subset of providers are used to calculate the percentages of patient visits for respiratory illness by age group.
The weekly hospitalization rate observed in week 50 was 2.5 per 100,000 population. The overall cumulative hospitalization rate was 11.3 per 100,000 population. This cumulative hospitalization rate is the second highest cumulative in-season hospitalization rate observed in week 50, following the 2022-2023 season (39.9). Cumulative in-season hospitalization rates observed in week 50 from 2010-2011 through 2021-2022 ranged from 0.3 to 6.2.
National Institute for Occupational Safety and Health: Monthly surveillance data on the prevalence of health-related workplace absenteeism among full-time workers in the United States are available from NIOSH.
On your Android phone, Backup by Google One allows you to seamlessly back up the photos, videos, contacts and messages most important to you, with up to 15GB of secure cloud storage included in your Google Account. You may also subscribe to Google One for even more storage and helpful features from Google products.
Nature Medicine asks leading researchers to name their top clinical trial for 2024, from base editing and a vaccine against HIV to artificial intelligence tools for lung cancer and patient triage.
New therapeutics and health technologies require fresh approaches to demonstrating safety and efficacy. This collection brings together key stakeholders to discuss how evidence-based medicine should evolve to assess these technological advances, from gene editing to artificial intelligence health algorithms.
A number of countries have stopped reporting or changed their frequency of reporting COVID-19 case and death counts to WHO. An outcome of these differences in reporting is that WHO may receive daily data from some countries, while other countries mayonly report data to WHO once every 14 days. In addition, countries differ in how they choose to report statistics; some countries provide their data attributed to specific dates while others who report less frequently may group data from 7 days intoa single statistic attributed to a week in their reporting. As of 25 August 2023, WHO declared that it is no longer necessary for Member States to report daily counts of cases and deaths to WHO and requested strengthening of weekly reporting.
New case and death counts from the Region of the Americas
Starting from the week commencing on 11 September 2023, the source of the data from the Region of the Americas was switched to the aggregated national surveillances,received through the COVID-19, Influenza, RSV and Other Respiratory Viruses program in the Americas. Data have been included retrospectively since 31 July 2023.
You shall not, in connection with your use of the Datasets published on data.who.int, state or imply that WHO endorses, or is affiliated with, you, or that WHO endorses your use of data.who.int, or any content, output, or analysis resultingfrom or related to the data.who.int, or any entity, organization, company, product or services.
df19127ead